Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
NOT YET RECRUITING
NCT07538466
PHASE1
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Sponsor: Addpharma Inc.
View on ClinicalTrials.gov
Summary
A Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232
Official title: An Open-label, Randomized, Single-dose, 2-sequence, 2-period, Crossover Study to Evaluate the Safety and Pharmacokinetics of AD-123 Compared to Coadministration of AD-1231 and AD-1232 in Healthy Adult Volunteers Under Fasting Conditions
Key Details
Gender
All
Age Range
19 Years - Any
Study Type
INTERVENTIONAL
Enrollment
50
Start Date
2026-04
Completion Date
2026-05
Last Updated
2026-04-20
Healthy Volunteers
Yes
Conditions
Interventions
DRUG
AD-123
AD-123 Oral Tablet
DRUG
AD-1231 and AD-1232
AD-1231 Oral Tablet + AD-1232 Oral Tablet
Locations (1)
H Plus Yangji Hospita
Seoul, South Korea